
APUS Market Capitalization Overview
Market Cap: $21.19M as of Jun 13, 2025
$21.19M
Past Month+$5.95M (39.01%)
As of Jun 13, 2025, APUS has a market capitalization of $21.19M. Over the past 30 days, its market cap has decreased by -55.46%, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of Apimeds Pharmaceuticals US Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
APUS Market Cap Formula = Stock Price * Shares Outstanding
The market cap of APUS helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Apimeds Pharmaceuticals US Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
APUS Market Cap Formula = Stock Price * Shares Outstanding
The market cap of APUS helps investors assess the company's size and compare it with competitors for better investment decisions.
APUS Market Cap & Key Trends
See Apimeds Pharmaceuticals US Inc’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in APUS
Order type
Buy in
Order amount
Est. shares
0 shares
APUS Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $20.84M | -55.46% |
May 8, 2025 | $46.79M | — |
APUS End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $21.19M | — |
FAQs About Apimeds Pharmaceuticals US Inc (APUS) Market Cap
As of Jun 13, 2025, the market capitalization of APUS is $21.19M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Apimeds Pharmaceuticals US Inc’s market capitalization has increased by 39.01%, changing from $15.24M to $21.19M as of Jun 13, 2025.
In the last 3 months, Apimeds Pharmaceuticals US Inc’s market capitalization has increased by —, changing from – to – as of –.
In the year –, Apimeds Pharmaceuticals US Inc’s market capitalization increased from – in January to – in December, reflecting a — change.